Bortezomib (Velcade) treatment for myeloma

Similar documents
Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Temozolomide (oral) with concurrent radiotherapy to the brain

Chemotherapy for lung cancer

Docetaxel (Taxotere) This booklet explains what docetaxel is, when it may be prescribed, how it works and what side effects may occur.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T. Patient s first names. Date of birth.

Chemotherapy for non-small cell lung cancer

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?

Other treatments for chronic myeloid leukaemia

FEC chemotherapy. The drugs that are used. How treatment is given

CVP Chemotherapy Regimen for Lymphoma Information for Patients

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

CHOP Chemotherapy Regimen for Lymphoma Information for Patients

Chemotherapy for head and neck cancers

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

Background Information Myeloma

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

Teriflunomide (Aubagio) 14mg once daily tablet

Treatment for pleural mesothelioma

Suspected pulmonary embolism (PE) in pregnant women

Deep Vein Thrombosis (DVT) in pregnancy

It can be devastating to be diagnosed with a cancer like multiple myeloma. But there are treatments that can help you live longer and feel better.

Breast Cancer. Breast Cancer Page 1

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

For the Patient: Paclitaxel injection Other names: TAXOL

ADVICE ON TRAVEL-RELATED DEEP VEIN THROMBOSIS

Venous Thrombosis and Pulmonary Embolism Treatment with Rivaroxaban

Answering your questions on Chronic Myeloid Leukaemia (CML)

11 Serious and life-threatening side effects can occur while taking EVISTA. These include 12 blood clots and dying from stroke:

QUESTIONS TO ASK MY DOCTOR

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

UNDERSTANDING MULTIPLE MYELOMA AND YOUR TREATMENT. It is not known if REVLIMID is safe and effective in children under 18 years of age My Moment

Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.

PATIENT MEDICATION INFORMATION

TC: Docetaxel and Cyclophosphamide

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

Insertion of a Peripherally Inserted Central Catheter (PICC Line)

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION

Preventing Blood Clots in Adult Patients. Information For Patients

Insertion of a Central Catheter (Hickman/Groshong Catheter)

For the Patient: Dasatinib Other names: SPRYCEL

Understanding Cytotoxic Chemotherapy

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Paclitaxel and Carboplatin

How To Take Xarelto

AC: Doxorubicin and Cyclophosphamide

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

FDA-Approved Patient Labeling IMPLANON (etonogestrel implant) Subdermal Use

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

Patient Information Leaflet

Total hip replacement

TCH: Docetaxel, Carboplatin and Trastuzumab

Patient Medication Guide Brochure

Radiotherapy for a mesothelioma

Oxford Anticoagulation & Thrombosis Service Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide)

Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer

Treating myeloma. Dr Rachel Hall Royal Bournemouth Hospital

Leflunomide Leflunomide

Symptoms of Hodgkin lymphoma

For the Patient: GDP Other names: LYGDP

FEC chemotherapy Factsheet

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

Ovarian cancer. Patient information from the BMJ Group. What is ovarian cancer? What are the symptoms?

AUBAGIO Conversation Starter

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

Ischaemic stroke 85% (85 in every 100 strokes)

TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide)

MEDICATION GUIDE. These serious side effects are described below:

Patient information. Goserelin Zoladex Breast Services Directorate PIF 1005 V3

Human Normal Immunoglobulin Solution for Intravenous Infusion.

Radioactive Ra 223 therapy. Information for patients Weston Park Hospital

Methotrexate treatment

Gemcitabine and Cisplatin

MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Allopurinol Allopurinol

METHOTREXATE TREATMENT

Information for patients receiving chemotherapy

Total knee replacement

Chemotherapy. What is chemotherapy? How does it work? What is cancer? How will I be given chemotherapy? Cannula

Living with multiple myeloma A guide for patients and caregivers

Having a Trans-Arterial Embolisation

What you need to know about. Multiple Myeloma. Based on a brochure from National Institutes of Health National Cancer Institute STDAVIDS.

Ultrasound-guided steroid injections in joints and soft tissues. Rheumatology Patient Information Leaflet

Chickenpox in pregnancy: what you need to know

Rivaroxaban for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

Local Steroid Injections to Joints and Soft Tissues. Rheumatology Patient Information Leaflet

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT

Femoral artery bypass graft (Including femoral crossover graft)

implant contraceptiv contraceptive contraceptive raceptiv contraceptive implant contraceptive contraceptive ontraceptive implant ontraceptive im

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

Hysterectomy for womb cancer

Transcription:

Patient information Bortezomib (Velcade) treatment for myeloma Your doctors have suggested that you are likely to benefit from a form of anti-cancer treatment called bortezomib (Velcade). They have weighed the expected benefits, in terms of bringing your myeloma under control, against the possibility of side effects. Your doctor will discuss these with you. If you are still unsure about the benefits then please ask. This fact sheet explains what you can expect from the treatment. What is bortezomib? Bortezomib is a new type of drug called a proteasome inhibitor. A proteasome is a type of enzyme which can be found in all our cells. It helps to regulate the growth and function of proteins in the cells. Myeloma cells have been found to be very sensitive to proteasome inhibitors. Bortezomib stops the proteasome from working causing the myeloma cells to die. Healthy cells may also be affected but can recover in the time between injections. Treatment plan Bortezomib is given over a three week (21 day) period. This is referred to as a cycle of treatment. It is given as an injection under the skin (subcutaneous) in your tummy or leg. This is usually done during a visit to Bud Flanagan Outpatient Department. Day 1 is the day you start treatment. You will be given the bortezomib on days 1, 4, 8, and 11. You will have a blood test before each injection to check that it is safe for you to have the treatment. During the third week you will not have any bortezomib. This is known as the rest week and will last for 10 days. The first cycle is then complete. You may receive between six and eight cycles of bortezomib. After four cycles you may have a bone marrow biopsy to see how the treatment is working. You will also be given dexamethasone (a steroid) to take with the bortezomib. You will need to take these on days 1, 2, 4, 5, 8, 9, 11 and 12. Your doctor will discuss this with you. You may also be given other tablets to minimise any side effects of the treatment. They are as follows: Aciclovir: to prevent herpes type infections like shingles. Lansoprazole: to protect the lining of your stomach from the steroids as they can irritate it. Fluconazole: to prevent you from getting fungal infections in your mouth. Myeloma Unit. Page 1 of 5

Co-trimoxazole: Allopurinol: a type of antibiotic to prevent you from getting certain types of chest infections. to prevent the build up of uric acid during the first few weeks of treatment. Side effects of bortezomib treatment All drugs can have some side effects and this includes bortezomib. The more common side effects are: Low blood count this treatment temporarily reduces the rate at which blood cells are produced in your bone marrow. This may cause: o anaemia (low red cell count) you may need blood transfusions. o neutropenia (low white cell count), which may increase your risk of developing an infection. o thrombocytopenia (low platelet count), which may increase your tendency to bruising and bleeding you may need platelet transfusions. This factsheet should be read together with the booklet Chemotherapy your questions answered. The booklet offers general information about chemotherapy and details about many of these side effects and how to manage them. If you have not yet received this booklet, please ask for it and any others mentioned in this factsheet. If you feel unwell at any time or have a temperature (38ºC/100ºF or higher) you should contact the hospital immediately as you may need to be admitted for intravenous antibiotics. If you feel unwell you should always check your temperature. Do not take paracetamol as this will mask any infection. For further information please refer to the Royal Marsden booklet Chemotherapy your questions answered. Numbness and tingling in the hands and feet this is called peripheral neuropathy and can be caused by the bortezomib. You must tell a member of the haematology team if walking or holding objects becomes difficult. It may improve over time once the treatment has stopped. Tiredness or lethargy you may become tired more easily after normal activities during your treatment. This is quite normal. Your tiredness should resolve in time. Loss of appetite you may find that you lose your appetite. Tell a member of the haematology team so they can refer you to a dietitian for advice. Constipation or diarrhoea bortezomib can cause either of these. Your doctor can prescribe medication for constipation. Tell the doctor or nurse if you have diarrhoea more than four times in 24 hours. Drink plenty of fluids. Dizziness (postural hypotension) bortezomib sometimes causes a temporary drop in blood pressure, so you may feel dizzy or light headed if you stand too Myeloma Unit. Page 2 of 5

quickly. You may be given intravenous fluids before your bortezomib injection to try and stop this from happening. Tell your doctor if you are taking medication for blood pressure and if you feel dizzy or light-headed. Reaction at injection site you may have a local reaction at the site of where you receive the injection. This maybe some redness, swelling or irritation. Please inform a member of the team looking after you if this is a problem. Side effects of steroids: as dexamethasone is a steroid there are a number of side effects you may experience when taking this. Most of these will go away once treatment is finished. Other than those mentioned above, you may notice the following: o Fluid retention you may notice swelling of your ankles (ankle oedema). Usually, this is mild and goes away when treatment ends. o Mood changes, euphoria or difficulty in sleeping You may find it helpful to discuss with your doctor, which time of day is best to take your steroids. It is usually best to avoid taking them in the evening if possible. o Blurred vision tell your doctor if this happens. o Irritation of the lining of the stomach dexamethasone may cause stomach pain, however you will be given drugs to prevent this from happening. It may also cause increased appetite and weight gain. o Steroid induced diabetes this may be permanent. It is important that you contact the hospital if you experience any of these side effects (see contact details below). With certain side effects, a treatment break or dose reduction may be necessary. You may find the booklet Chemotherapy your questions answered helpful for information about, and managing some of these side effects. Fertility, pregnancy and breast feeding We don t know what effect bortezomib has on fertility or a developing baby. Therefore we recommend the following advice given for chemotherapy drugs. o Fertility chemotherapy can damage the testes or ovaries. This may affect your ability to conceive (or father a child). Infertility can be temporary or more permanent. Sometimes in women chemotherapy can lead to premature menopause. If relevant to you, you may want to discuss the issue of fertility with your doctor before treatment is started. o Pregnancy during chemotherapy and for up to a year afterwards, if sperm or eggs are produced they may be abnormal. Treatment can also harm an unborn child. We recommend that you or your partner use a barrier method of contraception during treatment and for one year afterwards. If you know you are pregnant before starting treatment or become pregnant during treatment, you must tell your doctor immediately. Myeloma Unit. Page 3 of 5

o Breast feeding there is a risk of harm to a child who is being breastfed since the drugs may be concentrated in the milk. It is very important that women do not breast feed while receiving chemotherapy. We have listed the most common side effects of this chemotherapy. You may experience some or several of these side effects listed above and they may be mild, moderate or severe. Some can occasionally be life-threatening. As with all drugs there may be other side effects not mentioned here that you may experience. Because of the risk of side-effects it is important that you: Always tell your doctor if you suffer from any of these side effects, or if you have experienced any new symptoms since your last visit. Your doctor can help you by giving you medication or advice, to reduce or stop these side effects from occurring in the future. Always tell your doctor about any other medicine you are taking or planning to take, including herbal and complementary therapies. Always consult your doctor before having any other procedure, for example, dental work or vaccinations. Blood clots Some cancers increase the risk of developing blood clots. Chemotherapy drugs can also cause an increase in the risk of patients developing blood clots whilst they are on treatment. When a blood clot forms in a deep vein, usually the leg, it is called a deep vein thrombosis (DVT). This can cause the leg to swell. If a part of the clot breaks free, it may travel to the lungs, causing shortness of breath or chest pain. This is called a pulmonary embolus (PE). Blood clots can also happen in the arteries leading to a heart attack, stroke or disruption to the blood supply to a limb. Blood clots can be life threatening and treatment with blood-thinning drugs (anticoagulants) is usually given to help dissolve the clot and prevent further problems. Please inform your doctor immediately if you are worried you may have a blood clot. Airline travel is also associated with an increased risk of blood clots. It is important that you inform your hospital team of any travel plans whilst you are on treatment. Myeloma Unit. Page 4 of 5

Contact numbers If you have any questions about your treatment or side effects or if you feel unwell you must contact the hospital for advice. Clinical Nurse Specialist Myeloma: 0208 661 3657 Bud Flanagan Out Patients: 0208 661 3773 Bud Flanagan East: 0208 661 3776 Bud Flanagan West: 0208 661 3144 Site Practitioner on call/night sisters: 0208 642 6011 Bleep 017 or The Pharmacy Medicines Helpline: 020 8770 3821 Email: medicines.information@rmh.nhs.uk Myeloma Unit. Page 5 of 5